Navigation Links
Clinical Trial Best Practices: Savvy Marketers Plan Ahead with Early Communication Strategies
Date:1/23/2008

CHAPEL HILL, N.C., Jan. 23 /PRNewswire/ -- Marketers, who have the primary responsibility for communicating the results of clinical trials, see coordination and timing activities as top challenges for pharmaceutical companies when communicating trial data. One interviewed marketing executive states, "we have to worry about competitors stealing your thunder, but also worry about physicians forgetting what our trial was about."

According to a Best Practices, LLC benchmarking study, the marketing team creates preliminary communication plans to create a memorable identity linking study results to the product and to identify target audiences, key messages and effective activities for disseminating the study results long before the study even begins.

Download a complimentary research summary including sample best practices and data charts at http://www3.best-in-class.com/rr902.htm.

Planning and communication tactics along with other key strategies for optimizing the likelihood of a drug's market success are compiled in the benchmarking report, "From Breakthrough to Blockbuster: Best Practices in Communicating Clinical Trial Results."

The report presents the lessons learned and best practices gleaned from survey responses and interviews with pharmaceutical executives at world-class companies, including Abbott, AstraZeneca, Aventis, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen, Merck, Novartis, Schering-Plough and Wyeth. In the report, executives reflect upon the critical steps to communicating clinical trial results to diverse physician, managed care, investor and consumer audiences. Specifically the report examines the following areas:

-- Establishing a landmark clinical study

-- Choosing winning tactics for communicating study findings to

physicians, managed care organizations, investors and consumers

-- Avoiding the "cl
'/>"/>

SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Sept. 2, 2014  Cyberonics, Inc. ... from the ANTHEM-HF clinical study.  Results of the ... during a major European cardiology congress and concurrently ... show Autonomic Regulation Therapy (ART) in patients ... impaired heart function is safe, improves the heart,s ...
(Date:9/2/2014)... Calif. , Sept. 2, 2014  Abaxis, Inc. ... manufacturing point-of-care blood instrumentation and consumables to the medical, ... Severson , Chairman and Chief Executive Officer, will present ... September 10, 2014 at 10:20 a.m. ET. The conference ... in New York City . ...
(Date:9/2/2014)... , Sept. 2, 2014  Hologic, Inc. (NASDAQ: ... and Chief Executive Officer, will present at the Morgan Stanley ... , New York on Tuesday, September ... parties are invited to listen to the live audio webcast ... at www.hologic.com/investors-overview . An archive of the presentation will ...
Breaking Medicine Technology:ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 2ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 3ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 4ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 5Abaxis, Inc. to Present at the Morgan Stanley Global Healthcare Conference 2
... MADISON, Wis., Aug. 8, 2011 Symphony Corporation, ... the acquisition of JGI, a New Jersey-based Human ... significant presence in the healthcare industry nationally.  Symphony,s ... its offerings to provide the highest level of ...
... DIEGO, Aug. 8, 2011 HUYA Bioscience International, a ... strategic partnership with the Shanghai Jiao Tong University School ... assist King,s Lab in accelerating the development of their ... provides HUYA with access to and first review of ...
Cached Medicine Technology:Symphony Corporation Acquires JGI to Provide End-to-End Services for Healthcare IT 2HUYA Bioscience International and Shanghai Jiao Tong University King's Lab Form Alliance 2HUYA Bioscience International and Shanghai Jiao Tong University King's Lab Form Alliance 3
(Date:9/2/2014)... news release is available in Spanish . ... Granada have found, through an experiment conducted on rats, that ... of great use for groups with bone disease problems, such ... also revealed that vegetal proteinin the case of the present ... protein), since the former increased the level of calcium in ...
(Date:9/2/2014)... Somerset, N.J. (PRWEB) September 02, 2014 ... delivery technologies and development solutions for drugs, biologics ... support of its strategic partner, Eli Lilly’s growth, ... clinical packaging lines at its Philadelphia Clinical Supply ... prefilled syringe packaging capabilities in its clinical supply ...
(Date:9/2/2014)... Australia (PRWEB) September 02, 2014 The ... has fluctuated over the past five years. Industry revenue ... of 1.0% over the five years through 2014-15, following ... have faced increasing external competition from alternate forms of ... and other online gambling platforms have all become increasingly ...
(Date:9/2/2014)... Based on new studies, concerns ... kidney and spleen surgeries, have continued to mount. ... patients. , An article in the "Public ... Titilope Oduyebo and Bradley J. Quade called, "Peritoneal ... on Nov 26, 2012 defines a morcellator ...
(Date:9/2/2014)... 2014 (HealthDay News) -- When it comes to excess pounds ... a new study finds. The research found that belly ... odds for high blood pressure more than overall body fat. ... high blood pressure. But it wasn,t clear how the location ... researchers at University of Texas Southwestern Medical Center in Dallas. ...
Breaking Medicine News(10 mins):Health News:Study conducted on rats suggests that hyperproteic diets can be beneficial for bones 2Health News:Catalent Supports Eli Lilly's Growing Global Clinical Trials Needs with New Investment in Automated Packaging Solutions 2Health News:Lotteries in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Lotteries in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:New York Law Firm Discusses Allegedly Dangerous Surgical Morcellator Devices And Cancer Risk 2Health News:New York Law Firm Discusses Allegedly Dangerous Surgical Morcellator Devices And Cancer Risk 3Health News:'Spare Tire' May Be Especially Bad for Your Blood Pressure 2
... simple blood test corresponding to the follicular phase (days ... optimal scheduling of breast MRI exams in premenopausal women ... repeat scans and non-diagnostic tests patients experience and providing ... to a study published in the December issue of ...
... Nov. 20 As more red flags are uncovered about ... played a significant role in enabling this to happen. Has ... of inclusion and acceptance into a dangerous unwillingness to acknowledge ... and author Dr. Gaby Cora asserts that dangerous behavior in ...
... , Unique Survey Takes First-Time Look at Employers, ... 20 More employers are taking steps to improve their ... prescribed, a move that could stave off more serious and ... the National Pharmaceutical Council (NPC). , Medication compliance, sometimes ...
... Keep your children ... Kiley. , ... 2009 -- During the exciting weeks leading up to the holidays, many people find themselves ... the spirit of the season. Among all this holiday cheer we often forget that unsafe ...
... ... a line of pacifiers affixed to stuffed animals, she not only thought she created ... years later, apparently someone else thought so as well, as Williams was one of ... , ...
... WOONSOCKET, R.I., Nov. 20 CVS/pharmacy kicks off its annual ... St. Jude Children,s Research Hospital Thanks and Giving ... CVS/pharmacy store colleagues will encourage customers to add $1 to ... of St. Jude, one of the world,s premier centers for ...
Cached Medicine News:Health News:Psychiatrist Says Political Correctness Is Costing Lives 2Health News:Medication Compliance Is a Key Concern for Employers, According to New Survey 2Health News:Medication Compliance Is a Key Concern for Employers, According to New Survey 3Health News:Parents: Holiday Safety Tips from Massachusetts Child Injury Lawyer Thomas M. Kiley 2Health News:Parents: Holiday Safety Tips from Massachusetts Child Injury Lawyer Thomas M. Kiley 3Health News:Pacimals Founder Recognized in Time Magazine's "Inventors and Their Inventions" Special Section 2Health News:CVS/pharmacy Kicks Off Annual Thanks and Giving(R) Campaign for the St. Jude Children's Research Hospital 2
... Wheaton Harness™ A Pavlik-type harness with ... the treatment of congenital hip dysplasia. ... lining, and antislip foot pieces.,Color-coded anterior ... adjustments can be made while the ...
... cost walker features a non-skid rocker outsole ... profile design minimizes leg length discrepancy. Three ... strapping quick and easy. Steel uprights are ... ankle and bulky bandaging. Designed for easy ...
... walker provides comfortable stability for acute ankle ... leg, stress fractures of the lower leg ... ankle. Extension pads for the liner are ... Tide walker with midcalf uprights, is ideal ...
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
Medicine Products: